Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels

Conditions: Hematocrit Change; Cardiovascular Prevention; Empagliflozin; SGLT2-Inhibitors; Tissue Oxygenation Interventions: Drug: Empagliflozin10Mg Tab Sponsors: Aristotle University Of Thessaloniki Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials